Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

9536 ARTÍCULOS , VIENDO DEL 9361 AL 9375

Retinal vascular alterations in cognitive impairment: A multicenter study in China

Shi Q, Ni A, Li K, Su W, Xie W, Zheng H, Wang M, Xiao Z, Wu W, Shi K, Zhang P, Yan B, Ding D, Kwok T, Zhao Q, Zhang J.

Alzheimers Dement. 2025 Feb;21(2):e14593. doi: 10.1002/alz.14593.

Japanese participant data from three gantenerumab trials in early Alzheimer's disease

Asada T, Thanasopoulou A, Delmar P, Wojtowicz J, Smith J, Yoshiyama Y, Yokoi K, Watanabe C, Isozaki M, Ozaki R, Ishida T, Tatsuda H, Tamaoka A.

Alzheimers Dement. 2025 Apr;21(4):e70192. doi: 10.1002/alz.70192.

Oral Diseases Are Associated with Cognitive Decline and Dementia

Gao C, Kang J.

Adv Exp Med Biol. 2025;1472:171-183. doi: 10.1007/978-3-031-79146-8_11.

Long-Term Therapy With Transcranial Magnetic Stimulation in Primary Progressive Aphasia: A Randomized Clinical Trial

Fernández-Romero L, Cabrera-Martin MN, Delgado-Alonso C, Suárez-Coalla P, Grasso SM, Portolés A, Pérez-Macías N, Carreras MT, Díez-Cirarda M, Gil-Moreno MJ, Olazarán J, Vieira A, Oliver-Mas S, Gómez-Pinedo U, Matías-Guiu J, Matias-Guiu JA.

JAMA Netw Open. 2025 Aug 1;8(8):e2526129. doi: 10.1001/jamanetworkopen.2025.26129.

Safety, tolerability, immunogenicity, and efficacy of ABvac40 active immunotherapy against Aβ40 in patients with mild cognitive impairment or very mild Alzheimer's disease: A randomized, double-blind, placebo-controlled phase 2 study

Pascual-Lucas M, Lacosta AM, Montañés M, Canudas J, Loscos J, Monleón I, Allué JA, Sarasa L, Fandos N, Romero J, Sarasa M, Torres M, Whyms D, Terencio J, Piñol-Ripoll G, Boada M.

Alzheimers Dement. 2025 Oct;21(10):e70776. doi: 10.1002/alz.70776.

Effect of acupuncture on vascular cognitive impairment (VCI): A randomized controlled trial

Bai L, Cheng HL, Zhang WD, Hu PJ, Xu FY, Liu YQ, Dai F, Zhang LY.

Medicine (Baltimore). 2025 Sep 19;104(38):e44257. doi: 10.1097/MD.0000000000044257.

Gamma oscillation modulation for cognitive impairment: A systematic review

Bartolini E, Di Crosta A, La Malva P, Marin A, Ceccato I, Prete G, Mammarella N, Di Domenico A, Palumbo R.

J Alzheimers Dis. 2025 May;105(2):331-350. doi: 10.1177/13872877251328698. Epub 2025 Mar 28.

Brain patterns and risk factors in the FINGER RCT multimodal lifestyle intervention

Lorenzon G, Marseglia A, Mohanty R, Lehtisalo J, Poulakis K, Ngandu T, Solomon A, Kivipelto M, Westman E.

J Prev Alzheimers Dis. 2025 Dec;12(10):100390. doi: 10.1016/j.tjpad.2025.100390. Epub 2025 Sep 24.

Synapse vulnerability and resilience across the clinical spectrum of dementias

Taddei RN, Duff KE.

Nat Rev Neurol. 2025 Jul;21(7):353-369. doi: 10.1038/s41582-025-01094-7. Epub 2025 May 22.

Dietary Factors and Interventions for Cognitive Impairment and Dementia

Dawson AL, Willette AA.

Nutrients. 2025 Jan 8;17(2):210. doi: 10.3390/nu17020210.

Social Isolation, Loneliness, and Cognitive Health

Umoh ME.

Clin Geriatr Med. 2025 Aug;41(3):357-368. doi: 10.1016/j.cger.2025.04.007. Epub 2025 May 27.

Therapeutic strategies in vascular cognitive impairment: A systematic review and meta-analysis

Masserini F, Gendarini C, Baso G, Salvadori E, Pantoni L.

Alzheimers Dement. 2025 Nov;21(11):e70840. doi: 10.1002/alz.70840.

The Alzheimer's Association clinical practice guideline for the diagnostic evaluation, testing, counseling, and disclosure of suspected Alzheimer's disease and related disorders (DETeCD-ADRD): Validated clinical assessment instruments

Atri A, Dickerson BC, Clevenger C, Karlawish J, Knopman D, Lin PJ, Norman M, Onyike C, Sano M, Scanland S, Carrillo M.

Alzheimers Dement. 2025 Jan;21(1):e14335. doi: 10.1002/alz.14335. Epub 2024 Dec 23.

Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer's Association Workgroup 2024 for Alzheimer Disease

Mendes AJ, Ribaldi F, Pievani M, Boccalini C, Garibotto V, Frisoni GB; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2025 Jun 10;104(11):e213675. doi: 10.1212/WNL.0000000000213675. Epub 2025 May 13.

The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis

Hsu CW, Hsu TW, Kao YC, Lin YH, Thompson T, Carvalho AF, Stubbs B, Tseng PT, Yang FC, Tsai CK, Yu CL, Tu YK, Liang CS.

J Prev Alzheimers Dis. 2025 Sep;12(8):100195. doi: 10.1016/j.tjpad.2025.100195. Epub 2025 May 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias